The recent FDA approval for AstraZeneca’s Nexium 24 hour, or Esomeprazole, was exciting news for the pharmaceutical world. With over sixty million Americans suffering from heartburn at least once a month the advent of a 24 hour treatment that is easy to access is relieving. As an OTC or over the counter treatment for gastroesophageal[…]
Esomeprazole 24 Hour Now OTC
Anti-ulcerant, Drug Research & Development API, Gastrointestinal Agent, OTC and Compounding Product Tags: asthmaproton pump inhibitor Apr 24, 2014
The Many Faces of Esomeprazole
Anti-ulcerant, Gastrointestinal Agent, Patent Expiration 2014 Tags: gastroesophageal reflux diseaseproton pump inhibitor Jun 12, 2012
Patients suffering from Gastroesophageal Reflux Disease (GERD), benefit greatly from esomeprazole. Also known as Prilosec I.V. in the United States, AstraZeneca will see their patent of this breakout drug expire in May of 2014. The International Foundation for Functional Gastrointestinal Disorders recently reported that health professionals from the American Gastroenterological Association estimate that 33 percent[…]
Lansoprazole outruns Ranitidine in the long term battle of GERD treatment
Bulk Active Ingredient, OTC and Compounding Product Tags: gastroesophageal reflux diseaseproton pump inhibitor Sep 20, 2011
In developed nations, between 20-40 percent of adults experience heartburn on a regular basis. Heartburn is characterized by a burning sensation that rises from the stomach towards the chest and neck. It has often been mistaken as angina, a symptom of heart attack. Heartburn is the primary symptom of gastroesophageal reflux disease (GERD). When left[…]
